查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1490308

精准医疗市场，按类型、适应症、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Precision Medicine Market, By Type, By Indication, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年精准医疗市场规模为301.542亿美元，2024年至2032年复合年增长率为12.40%。

精准医疗市场-市场动态

精准医学利用遗传学和蛋白质进行个人化治疗，推动市场成长

精准医学利用患者的基因和蛋白质来创建专门针对其特定疾病的个人化治疗。由于精准医学领域的单核苷酸多态性和微阵列/生物晶片等关键发现，预计市场在不久的将来将出现显着增长。研究人类基因组对于精准医学的进步至关重要，并且能够透过分析每位患者的遗传学、分子组成和临床特征来彻底改变每位患者的医疗护理，从而为治疗疾病提供量身定制的治疗方法。上述因素预计将在未来几年推动精准医疗的需求。此外，预计癌症病例的增加将推动对个人化治疗和检测的精准医疗的需求，从而对市场扩张产生积极影响。 2018年，美国新诊断出近170万癌症病例。

精准医疗市场-关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 12.40% 左右的复合年增长率成长

根据类型细分，预计抑制剂药物将在 2023 年显示最大的市场份额

根据适应症细分，肿瘤学是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

精准医疗市场-細項分析：

全球精准医学市场根据类型、适应症、最终用户和地区进行细分。

市场依类型分为三类：抑制剂药物、单株抗体、细胞和基因疗法、抗病毒和抗逆转录病毒药物以及其他治疗产品。 2023年，由于抑制剂药物有效性的提高以及大量商业批准药物等因素，抑制剂药物类别将占据最大的市场份额。此外，抑制剂药物涵盖广泛的适应症，包括肿瘤学和罕见疾病。

市场依适应症分为两类：肿瘤、罕见疾病、传染病、血液疾病和其他适应症。从 2023 年到 2032 年，肿瘤学类别在市场上占据主导地位。然而，由于精准医疗的可用性增加，中枢神经系统是预测期内成长最快的类别。中枢神经系统标靶药物预测（CNS TAP）系统的开发是为了帮助根据患者特异性基因组资料选择精准医学疗法。

精准医疗市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲地区。这些区域根据开展业务的国家进一步划分。就收入而言，北美将在 2023 年成为最大的市占率持有地区，并预计在未来几年将继续保持这一地位。癌症发病率的增加以及该地区知名市场参与者的存在预计将成为推动该地区市场扩张的关键驱动力。此外，对精准医疗的需求主要是由政府的积极倡议和增加投资来创造最佳疾病管理的新颖解决方案所推动的。

亚太地区精准医疗市场预计在 2023 年至 2032 年间将以最快的复合年增长率发展。此外，中国精准医疗产业市场占有率最大，而印度精准医疗市场在亚太地区成长最快。

精准医疗市场-竞争格局：

主要市场参与者正在大力投资研发以扩展其产品线，这将有助于精准医疗市场进一步成长。市场参与者也在寻求策略措施来扩大其全球足迹，包括新产品发布、併购、合约协议、增加投资以及与其他企业的合作。精准医疗竞争对手必须提供具有成本效益的产品，才能在竞争日益激烈且不断上升的市场环境中扩张和生存。

最近的发展：

2022 年 1 月，阿斯特捷利康和 Scorpion Therapeutics 同意合作开发、行销和发现针对迄今为止难以靶向的癌症蛋白的精准疗法。它可以透过克服靶向转录因子和覆盖服务不足的患者群体的挑战来改变肿瘤治疗。它专注于称为转录因子的蛋白质，它调节重要的生理过程和基因表现。

目录

第一章：精准医疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的精准医疗市场片段
    • 按适应症分類的精准医疗市场片段
    • 最终用户的精准医疗市场片段
    • 按国家/地区分類的精准医疗市场摘要
    • 按地区分類的精准医疗市场片段
  • 竞争洞察

第 3 章：精准医学主要市场趋势

  • 精准医疗市场驱动因素
    • 市场驱动因素的影响分析
  • 精准医疗市场限制
    • 市场限制影响分析
  • 精准医疗市场机会
  • 精准医疗市场未来趋势

第 4 章：精准医疗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：精准医疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：精准医疗市场格局

  • 2023 年精准医疗市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：精准医疗市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 抑制剂药物
    • 单株抗体
    • 细胞与基因治疗
    • 抗病毒和抗逆转录病毒药物
    • 其他治疗产品

第 8 章：精准医疗市场 - 依适应症分类

  • 概述
    • 按指标分類的细分市场占有率分析
    • 肿瘤学
    • 罕见疾病
    • 传染性疾病
    • 血液系统疾病
    • 其他适应症

第 9 章：精准医疗市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院和诊所
    • 家庭护理设置

第 10 章：精准医疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美精准医疗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按指标）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲精准医疗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模与预测（按指标）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区精准医疗主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模与预测（依指标）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲精准医疗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按指标）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲精准医疗主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（依指标）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第11章：关键供应商分析-精准医疗产业

  • 竞争仪表板
  • 公司简介
    • Hoffmann-La Roche Ltd. (Switzerland)
    • Novartis AG (Switzerland)
    • Pfizer Inc. (US)
    • Bristol Myers Squibb (US)
    • AstraZeneca (UK)
    • Gilead Sciences, Inc. (US)
    • AbbVie Inc. (US)
    • Eli Lilly and Company (US)
    • GlaxoSmithKline plc (UK)
    • Sanofi (France)
    • Johnson & Johnson (US)
    • Merck KGaA (Germany)
    • Amgen, Inc. (US)
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2882

REPORT HIGHLIGHT

Precision Medicine Market size was valued at USD 30,154.2 Million in 2023, expanding at a CAGR of 12.40% from 2024 to 2032.

Precision medicine, also known as personalized medicine or individualized medicine, is a method of healthcare that considers individual differences in genes, environment, and lifestyle when developing medical treatment plans and actions. Rather of taking a one-size-fits-all strategy, precision medicine seeks to personalize medical decisions and treatments to the unique characteristics of each patient.

Precision Medicine Market- Market Dynamics

Precision Medicine Utilizes Genetics and Proteins for Personalized Treatments, Driving Market Growth

Precision medicine uses the patient's genes and proteins to create a personalized treatment specifically tailored to treat their specific disease. Due to key findings like single nucleotide polymorphism and microarray/biochips in the realm of precision medicine, the market is anticipated to see significant growth in the near future. Studying the human genome is crucial for the advancement of precision medicine and has the ability to revolutionize medical care for each patient by analyzing their genetics, molecular makeup, and clinical features to provide tailored treatments for curing diseases. The mentioned factors are expected to boost the demand for precision medicine in the coming years. In addition, an increase in cancer cases is projected to drive the need for precision medicine for individualized treatments and testing, positively impacting market expansion. In the United States in 2018, close to 1.7 Million new cancer cases were diagnosed.

Precision Medicine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.40% over the forecast period (2024-2032)

Based on Type segmentation, Inhibitor drugs was predicted to show maximum market share in the year 2023

Based on Indication segmentation, Oncology was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Precision Medicine Market- Segmentation Analysis:

The Global Precision Medicine Market is segmented on the basis of Type, Indication, End User, and Region.

The market is divided into three categories based on Type: Inhibitor drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-retroviral drugs and Other Therapeutic Products. In 2023, the inhibitor drugs category accounted for the biggest share of the market due to factors such as increased effectiveness of inhibitor pharmaceuticals and a significant number of commercially approved drugs. Furthermore, inhibitor medications cover a wide range of indications, including oncology and uncommon illnesses.

The market is divided into two categories based on Indication: Oncology, Rare Diseases, Infectious diseases, Hematological disorders, and Other indications. The oncology category dominated the market from 2023 to 2032. Precision oncology is a rapidly emerging and promising research subject that allows for individualized therapy based on an individual's molecular and genetic traits. However, the central nervous system is the fastest-growing category over the predicted period, owing to the increased availability of precision medicine. The central nervous system Targeted Agent Prediction (CNS TAP) System was developed to help in the selection of precision medicine therapies based on patient-specific genomic data.

Precision Medicine Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. In terms of revenue, North America is the largest market share holding region in 2023 and is expected to continue its position in the future years. The increasing frequency of cancer, as well as the presence of prominent market players in the region, are projected to be key drivers driving market expansion in the region. Furthermore, demand for precision medicine is being driven mostly by positive government initiatives and increased investment in creating novel solutions for optimal illness management.

The Asia-Pacific precision medicine market is predicted to develop at the quickest CAGR between 2023 and 2032. This is owing to the availability of low-cost clinical trials for cutting-edge precision medicine, as well as significant investments in healthcare facilities and technology. Furthermore, the Chinese precision medicine industry had the biggest market share, while India's precision medicine market was the fastest-growing in the Asia-Pacific region.

Precision Medicine Market- Competitive Landscape:

Major market players are investing heavily in research and development to extend their product lines, which will help the precision medicine market grow even more. Market participants are also pursuing strategic measures to expand their global footprint, including new product launches, mergers and acquisitions, contractual agreements, higher investments, and collaboration with other businesses. Precision medicine competitors must provide cost-effective products in order to expand and survive in an increasingly competitive and rising market environment.

Recent Developments:

In January 2022, AstraZeneca and Scorpion Therapeutics have agreed to collaborate on the development, marketing, and discovery of precision therapies targeting hitherto difficult-to-target cancer proteins. It could transform oncology treatment by overcoming the challenges of targeting transcription factors and reaching underserved patient populations. It focuses on proteins known as transcription factors, which regulate important physiological processes and gene expression.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PRECISION MEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Hoffmann-La Roche Ltd. (Switzerland)

Novartis AG (Switzerland)

Pfizer Inc. (US)

Bristol Myers Squibb (US)

AstraZeneca (UK)

Gilead Sciences, Inc. (US)

AbbVie Inc. (US)

Eli Lilly and Company (US)

GlaxoSmithKline plc (UK)

Sanofi (France)

Johnson & Johnson (US)

Merck KGaA (Germany)

Amgen, Inc. (US)

Others

GLOBAL PRECISION MEDICINE MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Inhibitor drugs
  • Monoclonal Antibodies
  • Cell & Gene Therapy
  • Antiviral & Anti-retroviral drugs
  • Other Therapeutic Products

GLOBAL PRECISION MEDICINE MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Rare Diseases
  • Infectious diseases
  • Hematological disorders
  • Other indications

GLOBAL PRECISION MEDICINE MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Clinics
  • Home care settings

GLOBAL PRECISION MEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Precision Medicine Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Precision Medicine Market Snippet by Type
    • 2.1.2.Precision Medicine Market Snippet by Indication
    • 2.1.3.Precision Medicine Market Snippet by End User
    • 2.1.4.Precision Medicine Market Snippet by Country
    • 2.1.5.Precision Medicine Market Snippet by Region
  • 2.2.Competitive Insights

3.Precision Medicine Key Market Trends

  • 3.1.Precision Medicine Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Precision Medicine Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Precision Medicine Market Opportunities
  • 3.4.Precision Medicine Market Future Trends

4.Precision Medicine Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Precision Medicine Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Precision Medicine Market Landscape

  • 6.1.Precision Medicine Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Precision Medicine Market - By Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2.Inhibitor drugs
    • 7.1.3.Monoclonal Antibodies
    • 7.1.4.Cell & Gene Therapy
    • 7.1.5.Antiviral & Anti-retroviral drugs
    • 7.1.6.Other Therapeutic Products

8.Precision Medicine Market - By Indication

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 8.1.2.Oncology
    • 8.1.3.Rare Diseases
    • 8.1.4.Infectious diseases
    • 8.1.5.Hematological disorders
    • 8.1.6.Other indications

9.Precision Medicine Market - By End User

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2.Hospitals and Clinics
    • 9.1.3.Home care settings

10.Precision Medicine Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Precision Medicine Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Precision Medicine Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Precision Medicine Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Precision Medicine Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Precision Medicine Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Precision Medicine Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Hoffmann-La Roche Ltd. (Switzerland)
    • 11.2.2.Novartis AG (Switzerland)
    • 11.2.3.Pfizer Inc. (US)
    • 11.2.4.Bristol Myers Squibb (US)
    • 11.2.5.AstraZeneca (UK)
    • 11.2.6.Gilead Sciences, Inc. (US)
    • 11.2.7.AbbVie Inc. (US)
    • 11.2.8.Eli Lilly and Company (US)
    • 11.2.9.GlaxoSmithKline plc (UK)
    • 11.2.10.Sanofi (France)
    • 11.2.11.Johnson & Johnson (US)
    • 11.2.12.Merck KGaA (Germany)
    • 11.2.13.Amgen, Inc. (US)
    • 11.2.14.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Precision Medicine Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Precision Medicine Market, by Type 2019-2032 (USD Million)
  • TABLE Precision Medicine Market: Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Precision Medicine Market, by Indication 2019-2032 (USD Million)
  • TABLE Precision Medicine Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Precision Medicine Market, by End User 2019-2032 (USD Million)
  • TABLE Precision Medicine Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Precision Medicine Market, by Region 2019-2032 (USD Million)
  • TABLE North America Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Precision Medicine Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Precision Medicine Market, by Indication, 2019-2032 (USD Million)
  • TABLE North America Precision Medicine Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Precision Medicine Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Precision Medicine Market, by Indication, 2019-2032 (USD Million)
  • TABLE Europe Precision Medicine Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Precision Medicine Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Precision Medicine Market, by Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Precision Medicine Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Precision Medicine Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Precision Medicine Market, by Indication, 2019-2032 (USD Million)
  • TABLE Latin America Precision Medicine Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Precision Medicine Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Precision Medicine Market, by Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Precision Medicine Market, by End User, 2019-2032 (USD Million)